These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6477609)

  • 41. Experimental myasthenia gravis is inhibited by receptor-antireceptor complexes.
    Barkas T; Simpson JA
    J Clin Lab Immunol; 1982 Apr; 7(3):223-7. PubMed ID: 7097749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.
    Leite MI; Ströbel P; Jones M; Micklem K; Moritz R; Gold R; Niks EH; Berrih-Aknin S; Scaravilli F; Canelhas A; Marx A; Newsom-Davis J; Willcox N; Vincent A
    Ann Neurol; 2005 Mar; 57(3):444-8. PubMed ID: 15732104
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myasthenia gravis: T and B cell reactivities to the beta-bungarotoxin binding protein presynaptic membrane receptor.
    Link H; Sun JB; Lu CZ; Xiao BG; Fredrikson S; Höjeberg B; Olsson T
    J Neurol Sci; 1992 Jun; 109(2):173-81. PubMed ID: 1634899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IgG from "seronegative" myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor.
    Blaes F; Beeson D; Plested P; Lang B; Vincent A
    Ann Neurol; 2000 Apr; 47(4):504-10. PubMed ID: 10762162
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monoclonal antibodies specific for each of the two toxin-binding sites of Torpedo acetylcholine receptor.
    Dowding AJ; Hall ZW
    Biochemistry; 1987 Oct; 26(20):6372-81. PubMed ID: 3427011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isolation and characterization of human anti-acetylcholine receptor monoclonal antibodies from transgenic mice expressing human immunoglobulin loci.
    Protopapadakis E; Kokla A; Tzartos SJ; Mamalaki A
    Eur J Immunol; 2005 Jun; 35(6):1960-8. PubMed ID: 15915538
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antigenic modulation of junctional acetylcholine receptor is not sufficient to account for the development of myasthenia gravis in receptor immunized mice.
    Berman PW; Heinemann SF
    J Immunol; 1984 Feb; 132(2):711-7. PubMed ID: 6690616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MHC class II presentation of human acetylcholine receptor in Myasthenia gravis: binding of synthetic gamma subunit sequences to DR molecules.
    Yuen MH; Macklin KD; Conti-Fine BM
    J Autoimmun; 1996 Feb; 9(1):67-77. PubMed ID: 8845056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-acetylcholine receptor antibodies directed against the alpha-bungarotoxin binding site induce a unique form of experimental myasthenia.
    Gomez CM; Richman DP
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4089-93. PubMed ID: 6575398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Purification of high-affinity Fab fragments from experimental autoimmune myasthenia gravis rabbits and their effect on isolated acetylcholine receptors.
    Mihovilovic M; Martinez-Carrion M
    Biochemistry; 1979 Oct; 18(21):4522-8. PubMed ID: 497153
    [No Abstract]   [Full Text] [Related]  

  • 51. Restoration of 125I-alpha-bungarotoxin binding activity to the alpha subunit of Torpedo acetylcholine receptor isolated by gel electrophoresis in sodium dodecyl sulfate.
    Haggerty JG; Froehner SC
    J Biol Chem; 1981 Aug; 256(16):8294-7. PubMed ID: 7263653
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence for the presence of immunoreactive acetylcholine receptors on human thymus cells.
    Raimond F; Morel E; Bach JF
    J Neuroimmunol; 1984 Feb; 6(1):31-40. PubMed ID: 6200495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence that certain peripheral anti-acetylcholine receptor antibodies do not interact with brain BuTX binding sites.
    Morley BJ; Dwyer DS; Strang-Brown PF; Bradley RJ; Kemp GE
    Brain Res; 1983 Feb; 262(1):109-16. PubMed ID: 6831222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monoclonal antibodies against the alpha-bungarotoxin-binding protein of chick optic lobe.
    Betz H; Pfeiffer F
    J Neurosci; 1984 Aug; 4(8):2095-105. PubMed ID: 6470769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory effect of alpha-fetoprotein on the binding of myasthenia gravis antibody to acetylcholine receptor.
    Brenner T; Beyth Y; Abramsky O
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3635-9. PubMed ID: 6158053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Demonstration of acetylcholine receptor antibodies in the serum of myasthenia gravis patients applying affinity chromatographically purified human acetylcholine receptor preparations (author's transl)].
    Kalies I; Kalden JR; Heinz F; Janzen RW; Lachenmayer L
    Klin Wochenschr; 1979 Sep; 57(17):875-81. PubMed ID: 502355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A rapid immunoadsorbent radioimmunoassay for anti-acetylcholine receptor antibody.
    Tindall RS; Kent M; Wells L
    J Immunol Methods; 1981; 45(1):1-14. PubMed ID: 7288190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of a myasthenic serum on the acetylcholine receptors of C2 myotubes. I. Immunological distinction between the two toxin-binding sites of the receptor.
    Gu Y; Silberstein L; Hall ZW
    J Neurosci; 1985 Jul; 5(7):1909-16. PubMed ID: 4020425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Purification and characterization of nicotinic acetylcholine receptors from muscle.
    Kemp G; Morley B; Dwyer D; Bradley RJ
    Membr Biochem; 1980; 3(3):229-57. PubMed ID: 7382840
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Purification and characterization of the alpha-bungarotoxin binding protein from rat brain.
    Kemp G; Bentley L; McNamee MG; Morley BJ
    Brain Res; 1985 Nov; 347(2):274-83. PubMed ID: 4063809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.